secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0001193125-23-098461
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen announces acquisition of FlexBiosys for undisclosed cash, equity, and earnout
--------------------------------------------------------------------------------

- Repligen executed Equity Purchase Agreement to acquire all outstanding equity of FlexBiosys.
- Consideration comprises cash, equity, and performance-based earnout payments through year-end 2024.
- Transaction expected to close in Q2 2023, subject to satisfaction of conditions.
- No financial terms or valuation were disclosed in the SEC filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312523098461/0001193125-23-098461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312523098461/d460811d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-098461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer